Lukas von Stülpnagel

7PUBLICATIONS
99CO-AUTHORS
Artificial life and complex adaptive systemsRespiratory diseasesBehavioural epidemiologyCardiology (incl. cardiovascular diseases)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 23, 2025
Gender specific aspects of digital screening for atrial fibrillation: insights from the randomized eBRAVE-AF trial.

Luisa Freyer, Peter Spielbichler, Lukas von Stülpnagel

|Jul 24, 2025
Cardiac autonomic function score: a novel risk stratification tool in the cardiac intensive care unit based on periodic repolarization dynamics and deceleration capacity of heart rate (LMU-eICU study).

Mathias Klemm, Lukas von Stülpnagel, Valentin Ostermaier

|Dec 11, 2024
Impact of Age on Smartphone-Based Screening for Atrial Fibrillation: A Prespecified Subgroup Analysis of the eBRAVE-AF Trial.

Luisa Freyer, Peter Spielbichler, Lukas von Stülpnagel

|Jul 31, 2024
Angiotensin Receptor-Neprilysin Inhibitor Is Associated With Improved Cardiac Autonomic Function in Heart Failure.

Andreas A Boehmer, Tim Schubert, Moritz Rothe

|Mar 08, 2023
The DZHK research platform: maximisation of scientific value by enabling access to health data and biological samples collected in cardiovascular clinical studies.

Julia Hoffmann, Sabine Hanß, Monika Kraus

|Aug 28, 2022
Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial.

Konstantinos D Rizas, Luisa Freyer, Nikolay Sappler

Pageof 2

Frequent Collaborators

5 joint publications

Steffen Massberg

4 joint publications

Axel Bauer

4 joint publications

Konstantinos D Rizas

3 joint publications

Luisa Freyer